Delivery Order SPE2DB20D2104-SPE2DB24FV33Y
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,935.52 firm fixed-price contract is for the supply of NASCOBAL 500 MCG nasal sprays. The contract has an ultimate completion date of January 5, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NASCOBAL 500 MCG NASAL SPRAYS. The contract has a ceiling value of $30,299.21 and is a Firm Fixed Price agreement. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The $11,679.27 contract is for the supply of NASCOBAL 500 MCG nasal sprays to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NASCOBAL 500 MCG NASAL SPRAYS, a specialty medication, with a ceiling value of $23,075.34 and a period of performance through November 2023. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,464.34 firm fixed-price delivery order is for NASCOBAL 500 MCG NASAL SPRAYS and has a completion date of July 29, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of NASCOBAL 500 MCG NASAL SPRAYS. The contract has a potential value of $2,541.46 and a performance period through March 6, 2024. Amerisourcebergen Drug Corp, as a prime contractor, is responsible for delivering these pharmaceutical products to support military treatment programs and facilities. This order is part of a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,497.78 Firm Fixed Price Delivery Order is for the provision of NASCOBAL 500 MCG NASAL SPRAYS. The contract has an ultimate completion date of December 4, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,279.49 firm-fixed-price delivery order is for the supply of NASCOBAL 500 MCG NASAL SPRAYS, with a completion date of April 3, 2024. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) was issued by the Defense Logistics Agency (DLA) for the delivery of Nascobal 500 mcg nasal sprays. The $5,039.89 firm fixed-price delivery order has a completion date of May 23, 2022. The contract does not have any set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award, with ID SPE2DB20D2104|SPE2DB23FS57W, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,719.53 firm fixed-price delivery order is for the provision of NASCOBAL 500 MCG NASAL SPRAYS. The contract has an ultimate completion date of March 13, 2023 and was awarded on March 10, 2023. It is not designated as a set-aside. Amerisourcebergen Drug Corp, a subsidiary of...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FV33YDelivery Order
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of NASCOBAL 500 MCG nasal sprays. The firm-fixed-price contract, valued at $3,544.49, has a completion date of July 24, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 7/23/24 |